IP Verse

Concert Pharmaceuticals competitive analysis

Latest publications and patents of Concert Pharmaceuticals New

Explore the latest publications and patents granted to Concert Pharmaceuticals, showcasing their recent innovations and technological advancements.

Last updated on: Sep 23, 2025
Publication NumberPublication DateTitleLegal Status

Get instant update for new patents of Concert Pharmaceuticals

EP3450434
Feb 24, 2021Deuterated Derivatives Of RuxolitinibGranted And Under Opposition
EP3093290
Jan 24, 2018Morphinan CompoundsNo Opposition Filed Within Time Limit
EP2365808
Jan 10, 2018Combination Of Morphinan Compounds And Antidepressant For The Treatment Of Pseudobulbar Affect, Neurological Diseases, Intractable And Chronic Pain And Brain InjuryNo Opposition Filed Within Time Limit

Latest oppositions filed by Concert Pharmaceuticals

Explore patent oppositions filed by Concert Pharmaceuticals against competitors, revealing strategic technology disputes and market positioning.

Last updated on: Sep 25, 2025
Patent NumberTitleApplicantOpposition Date

Get instant updates on new opposition filings by the company

EP2635299
Methods For Treating Hair Loss DisordersTHE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORKApr 30, 2020
EP3184526
Pyrrolo[2,3-D]Pyrimidine Derivatives As Janus Kinase InhibitorINCYTEJun 28, 2019

Latest patents of Concert Pharmaceuticals opposed by its competitors

Explore Concert Pharmaceuticals's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Last updated on: Sep 25, 2025
Patent NumberGrant DateTitleTotal Oppositions
EP3450434
Feb 24, 2021Deuterated Derivatives Of Ruxolitinib1

Latest PTAB cases involving Concert Pharmaceuticals

Discover the latest PTAB cases involving Concert Pharmaceuticals, highlighting their recent legal challenges and patent disputes.

Last updated on: Sep 29, 2025
Proceeding NumberFiling DatePetitionerRespondentStatus

Get alerts for PTAB Cases involving Concert Pharmaceuticals

PGR2021-00006Oct 28, 2020INCYTECONCERT PHARMACEUTICALSFinal Written Decision
PGR2017-00034Jun 27, 2017CONCERT PHARMACEUTICALSINCYTEInstitution Denied
IPR2017-01256Apr 7, 2017INCYTECONCERT PHARMACEUTICALSFinal Written Decision

Peer Comparison New

IP litigation analysis comparing Concert Pharmaceuticals with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Sep 25, 2025
CompanyOppositions FiledOppositions FacedPTAB Cases FiledPTAB Cases FacedStrategy Type
CONCERT PHARMACEUTICALS2112Aggressive
INCYTE11221Defensive
THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK - 5 - 21Non-Active